ZhiyuanChen commited on
Commit
0a4ead7
·
verified ·
1 Parent(s): e382147

Upload folder using huggingface_hub

Browse files
Files changed (7) hide show
  1. README.md +394 -0
  2. config.json +39 -0
  3. license-faq.md +299 -0
  4. license.md +661 -0
  5. model.safetensors +3 -0
  6. tokenizer_config.json +69 -0
  7. vocab.txt +1030 -0
README.md ADDED
@@ -0,0 +1,394 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ ---
2
+ datasets:
3
+ - multimolecule/gencode-human
4
+ library_name: multimolecule
5
+ license: agpl-3.0
6
+ mask_token: <mask>
7
+ pipeline_tag: fill-mask
8
+ tags:
9
+ - Biology
10
+ - DNA
11
+ widget:
12
+ - example_title: prion protein (Kanno blood group)
13
+ mask_index: 21
14
+ mask_index_1based: 22
15
+ masked_char: A
16
+ output:
17
+ - label: CTGTT
18
+ score: 0.958619
19
+ - label: CTGGT
20
+ score: 0.032288
21
+ - label: CTTTT
22
+ score: 0.002582
23
+ - label: CTCTT
24
+ score: 0.001927
25
+ - label: CTATT
26
+ score: 0.001795
27
+ pipeline_tag: fill-mask
28
+ sequence_type: cDNA
29
+ task: fill-mask
30
+ text: ATGGCGAACCTTGGCTGCTGG<mask>GGTTCTCTTTGTGGCCACATGGAGTGACCTGGGCCTCTGC
31
+ - example_title: interleukin 10
32
+ mask_index: 11
33
+ mask_index_1based: 12
34
+ masked_char: A
35
+ output:
36
+ - label: GCTCT
37
+ score: 0.998642
38
+ - label: GCGCT
39
+ score: 0.000622
40
+ - label: GCTCC
41
+ score: 0.000233
42
+ - label: GCTCA
43
+ score: 0.00011
44
+ - label: GCTGT
45
+ score: 0.000109
46
+ pipeline_tag: fill-mask
47
+ sequence_type: cDNA
48
+ task: fill-mask
49
+ text: ATGCACAGCTC<mask>TGCTCTGTTGCCTGGTCCTCCTGACTGGGGTGAGGGCC
50
+ - example_title: Zaire ebolavirus
51
+ mask_index: 11
52
+ mask_index_1based: 12
53
+ masked_char: A
54
+ output:
55
+ - label: AATGA
56
+ score: 0.850157
57
+ - label: AAAGA
58
+ score: 0.086721
59
+ - label: AGTGA
60
+ score: 0.04054
61
+ - label: AAACA
62
+ score: 0.007653
63
+ - label: AAGGA
64
+ score: 0.005888
65
+ pipeline_tag: fill-mask
66
+ sequence_type: cDNA
67
+ task: fill-mask
68
+ text: AATGTTCAAAC<mask>GTGAAGCTCTGTTAGCTGATGGTCTTGCTAAAGCATTTCCTAGCAATATGATGGTAGTCACAGAGCGTGAGCAAAAAGAAAGCTTATTGCATCAAGCATCATGGCACCACACAAGTGATGATTTTGGTGAGCATGCCACAGTTAGAGGGAGTAGCTTTGTAACTGATTTAGAGAAATACAATCTTGCATTTAGATATGAGTTTACAGCACCTTTTATAGAATATTGTAACCGTTGCTATGGTGTTAAGAATGTTTTTAATTGGATGCATTATACAATCCCACAGTGTTAT
69
+ - example_title: SARS coronavirus
70
+ mask_index: 14
71
+ mask_index_1based: 15
72
+ masked_char: A
73
+ output:
74
+ - label: TCTCT
75
+ score: 0.992082
76
+ - label: TTTCT
77
+ score: 0.007138
78
+ - label: TCTTT
79
+ score: 0.000205
80
+ - label: TCCCT
81
+ score: 0.000116
82
+ - label: TCTGT
83
+ score: 0.000113
84
+ pipeline_tag: fill-mask
85
+ sequence_type: cDNA
86
+ task: fill-mask
87
+ text: ATGTTTATTTTCTT<mask>TTCTTACTCTCACTAGTGGTAGTGACCTTGACCGGTGCACCACTTTTGATGATGTTCAAGCTCCTAATTACACTCAACATACTTCATCTATGAGGGGGGTTTACTATCCTGATGAAATTTTTAGATCAGACACTCTTTATTTAACTCAGGATTTATTTCTTCCATTTTATTCTAATGTTACAGGGTTTCATACTATTAATCATACGTTTGACAACCCTGTCATACCTTTTAAGGATGGTATTTATTTTGCTGCCACAGAGAAATCAAATGTTGTCCGTGGTTGGGTTTTTGGTTCTACCATGAACAACAAGTCACAGTCGGTGATTATTATTAACAATTCTACTAATGTTGTTATACGAGCATGTAACTTTGAATTGTGTGACAACCCTTTCTTTGCTGTTTCTAAACCCATGGGTACACAGACACATACTATGATATTCGATAATGCATTTAAATGCACTTTCGAGTACATATCT
88
+ ---
89
+
90
+ # DNABERT
91
+
92
+ Pre-trained model on human genome using a masked language modeling (MLM) objective with k-mer tokenization.
93
+
94
+ ## Disclaimer
95
+
96
+ This is an UNOFFICIAL implementation of the [DNABERT: pre-trained Bidirectional Encoder Representations from Transformers model for DNA-language in genome](https://doi.org/10.1093/bioinformatics/btab083) by Yanrong Ji, Zhihan Zhou, et al.
97
+
98
+ The OFFICIAL repository of DNABERT is at [jerryji1993/DNABERT](https://github.com/jerryji1993/DNABERT).
99
+
100
+ > [!TIP]
101
+ > The MultiMolecule team has confirmed that the provided model and checkpoints are producing the same intermediate representations as the original implementation.
102
+
103
+ **The team releasing DNABERT did not write this model card for this model so this model card has been written by the MultiMolecule team.**
104
+
105
+ ## Model Details
106
+
107
+ DNABERT is a [bert](https://huggingface.co/google-bert/bert-base-uncased)-style model pre-trained on the human genome with k-mer tokenization in a self-supervised fashion. This means that the model was trained on the raw nucleotides of DNA sequences only, with an automatic process to generate inputs and labels from those texts. Please refer to the [Training Details](#training-details) section for more information on the training process.
108
+
109
+ ### Variants
110
+
111
+ - **[multimolecule/dnabert-5mer-3mer](https://huggingface.co/multimolecule/dnabert-5mer-3mer)**: The DNABERT model pre-trained on 3-mer data.
112
+ - **[multimolecule/dnabert-5mer-4mer](https://huggingface.co/multimolecule/dnabert-5mer-4mer)**: The DNABERT model pre-trained on 4-mer data.
113
+ - **[multimolecule/dnabert-5mer-5mer](https://huggingface.co/multimolecule/dnabert-5mer-5mer)**: The DNABERT model pre-trained on 5-mer data.
114
+ - **[multimolecule/dnabert-5mer-6mer](https://huggingface.co/multimolecule/dnabert-5mer-6mer)**: The DNABERT model pre-trained on 6-mer data.
115
+
116
+ ### Model Specification
117
+
118
+ <table>
119
+ <thead>
120
+ <tr>
121
+ <th>Variants</th>
122
+ <th>Num Layers</th>
123
+ <th>Hidden Size</th>
124
+ <th>Num Heads</th>
125
+ <th>Intermediate Size</th>
126
+ <th>Num Parameters (M)</th>
127
+ <th>FLOPs (G)</th>
128
+ <th>MACs (G)</th>
129
+ <th>Max Num Tokens</th>
130
+ </tr>
131
+ </thead>
132
+ <tbody>
133
+ <tr>
134
+ <td>dnabert-6mer</td>
135
+ <td rowspan="4">12</td>
136
+ <td rowspan="4">768</td>
137
+ <td rowspan="4">12</td>
138
+ <td rowspan="4">3072</td>
139
+ <td>89.19</td>
140
+ <td rowspan="4">96.86</td>
141
+ <td rowspan="4">48.43</td>
142
+ <td rowspan="4">512</td>
143
+ </tr>
144
+ <tr>
145
+ <td><b>dnabert-5mer</b></td>
146
+ <td>86.83</td>
147
+ </tr>
148
+ <tr>
149
+ <td>dnabert-4mer</td>
150
+ <td>86.24</td>
151
+ </tr>
152
+ <tr>
153
+ <td>dnabert-3mer</td>
154
+ <td>86.10</td>
155
+ </tr>
156
+ </tbody>
157
+ </table>
158
+
159
+ ### Links
160
+
161
+ - **Code**: [multimolecule.dnabert](https://github.com/DLS5-Omics/multimolecule/tree/master/multimolecule/models/dnabert)
162
+ - **Data**: [multimolecule/gencode-human](https://huggingface.co/datasets/multimolecule/gencode-human)
163
+ - **Paper**: [DNABERT: pre-trained Bidirectional Encoder Representations from Transformers model for DNA-language in genome](https://doi.org/10.1093/bioinformatics/btab083)
164
+ - **Developed by**: Yanrong Ji, Zhihan Zhou, Han Liu, Ramana V Davuluri
165
+ - **Model type**: [BERT](https://huggingface.co/google-bert/bert-base-uncased)
166
+ - **Original Repositories**: [jerryji1993/DNABERT](https://github.com/jerryji1993/DNABERT)
167
+
168
+ ## Usage
169
+
170
+ The model file depends on the [`multimolecule`](https://multimolecule.danling.org) library. You can install it using pip:
171
+
172
+ ```bash
173
+ pip install multimolecule
174
+ ```
175
+
176
+ ### Direct Use
177
+
178
+ #### Masked Language Modeling
179
+
180
+ > [!WARNING]
181
+ > Default transformers pipeline does not support K-mer tokenization.
182
+
183
+ You can use this model directly with a pipeline for masked language modeling:
184
+
185
+ ```python
186
+ import multimolecule # you must import multimolecule to register models
187
+ from transformers import pipeline
188
+
189
+ predictor = pipeline("fill-mask", model="multimolecule/dnabert-5mer")
190
+ output = predictor("ATCG<mask>TGCA")
191
+ ```
192
+
193
+ ### Downstream Use
194
+
195
+ #### Extract Features
196
+
197
+ Here is how to use this model to get the features of a given sequence in PyTorch:
198
+
199
+ ```python
200
+ from multimolecule import DnaBertModel
201
+ from transformers import AutoTokenizer
202
+
203
+
204
+ tokenizer = AutoTokenizer.from_pretrained("multimolecule/dnabert-5mer")
205
+ model = DnaBertModel.from_pretrained("multimolecule/dnabert-5mer")
206
+
207
+ text = "ATCGATCGATCGATCG"
208
+ input = tokenizer(text, return_tensors="pt")
209
+
210
+ output = model(**input)
211
+ ```
212
+
213
+ #### Sequence Classification / Regression
214
+
215
+ > [!NOTE]
216
+ > This model is not fine-tuned for any specific task. You will need to fine-tune the model on a downstream task to use it for sequence classification or regression.
217
+
218
+ Here is how to use this model as backbone to fine-tune for a sequence-level task in PyTorch:
219
+
220
+ ```python
221
+ import torch
222
+ from multimolecule import DnaBertForSequencePrediction
223
+ from transformers import AutoTokenizer
224
+
225
+
226
+ tokenizer = AutoTokenizer.from_pretrained("multimolecule/dnabert-5mer")
227
+ model = DnaBertForSequencePrediction.from_pretrained("multimolecule/dnabert-5mer")
228
+
229
+ text = "ATCGATCGATCGATCG"
230
+ input = tokenizer(text, return_tensors="pt")
231
+ label = torch.tensor([1])
232
+
233
+ output = model(**input, labels=label)
234
+ ```
235
+
236
+ #### Token Classification / Regression
237
+
238
+ > [!NOTE]
239
+ > This model is not fine-tuned for any specific task. You will need to fine-tune the model on a downstream task to use it for token classification or regression.
240
+
241
+ Here is how to use this model as backbone to fine-tune for a nucleotide-level task in PyTorch:
242
+
243
+ ```python
244
+ import torch
245
+ from multimolecule import DnaBertForTokenPrediction
246
+ from transformers import AutoTokenizer
247
+
248
+
249
+ tokenizer = AutoTokenizer.from_pretrained("multimolecule/dnabert-5mer")
250
+ model = DnaBertForTokenPrediction.from_pretrained("multimolecule/dnabert-5mer")
251
+
252
+ text = "ATCGATCGATCGATCG"
253
+ input = tokenizer(text, return_tensors="pt")
254
+ label = torch.randint(2, (len(text), ))
255
+
256
+ output = model(**input, labels=label)
257
+ ```
258
+
259
+ #### Contact Classification / Regression
260
+
261
+ > [!NOTE]
262
+ > This model is not fine-tuned for any specific task. You will need to fine-tune the model on a downstream task to use it for contact classification or regression.
263
+
264
+ Here is how to use this model as backbone to fine-tune for a contact-level task in PyTorch:
265
+
266
+ ```python
267
+ import torch
268
+ from multimolecule import DnaBertForContactPrediction
269
+ from transformers import AutoTokenizer
270
+
271
+
272
+ tokenizer = AutoTokenizer.from_pretrained("multimolecule/dnabert-5mer")
273
+ model = DnaBertForContactPrediction.from_pretrained("multimolecule/dnabert-5mer")
274
+
275
+ text = "ATCGATCGATCGATCG"
276
+ input = tokenizer(text, return_tensors="pt")
277
+ label = torch.randint(2, (len(text), len(text)))
278
+
279
+ output = model(**input, labels=label)
280
+ ```
281
+
282
+ ## Training Details
283
+
284
+ DNABERT used Masked Language Modeling (MLM) as the pre-training objective: taking a sequence, the model randomly masks 15% of the tokens in the input then runs the entire masked sentence through the model and has to predict the masked tokens. This is comparable to the Cloze task in language modeling.
285
+
286
+ ### Training Data
287
+
288
+ The DNABERT model was pre-trained on the human genome. The training data consists of DNA sequences from the human reference genome (GRCh38.p13), with all sequences containing only the four canonical nucleotides (A, T, C, G).
289
+
290
+ ### Training Procedure
291
+
292
+ #### Preprocessing
293
+
294
+ DNABERT used masked language modeling (MLM) as the pre-training objective. The masking procedure is similar to the one used in BERT:
295
+
296
+ - 15% of the tokens are masked. In the last 20,000 steps, the masking rate is increased to 20%.
297
+ - In 80% of the cases, the masked tokens are replaced by `<mask>`.
298
+ - In 10% of the cases, the masked tokens are replaced by a random token (different) from the one they replace.
299
+ - In the 10% remaining cases, the masked tokens are left as is.
300
+
301
+ Since DNABERT used k-mer tokenizer, it masks the entire k-mer instead of individual nucleotides to avoid information leakage.
302
+
303
+ For example, if the k-mer is 3, the sequence `"TAGCGTAT"` will be tokenized as `["TAG", "AGC", "GCG", "CGT", "GTA", "TAT"]`. If the nucleotide `"C"` is masked, the adjacent tokens will also be masked, resulting `["TAG", "<mask>", "<mask>", "<mask>", "GTA", "TAT"]`.
304
+
305
+ #### Pre-training
306
+
307
+ The model was trained on 8 NVIDIA RTX 2080Ti GPUs.
308
+
309
+ - Batch size: 2,000
310
+ - Steps: 120,000
311
+ - Learning rate: 4e-4
312
+ - Learning rate scheduler: Linear
313
+ - Learning rate warm-up: 10,000 steps
314
+
315
+ ## Citation
316
+
317
+ ```bibtex
318
+ @ARTICLE{Ji2021-cj,
319
+ title = "{DNABERT}: pre-trained Bidirectional Encoder Representations
320
+ from Transformers model for {DNA-language} in genome",
321
+ author = "Ji, Yanrong and Zhou, Zhihan and Liu, Han and Davuluri, Ramana V",
322
+ abstract = "MOTIVATION: Deciphering the language of non-coding DNA is one of
323
+ the fundamental problems in genome research. Gene regulatory
324
+ code is highly complex due to the existence of polysemy and
325
+ distant semantic relationship, which previous informatics
326
+ methods often fail to capture especially in data-scarce
327
+ scenarios. RESULTS: To address this challenge, we developed a
328
+ novel pre-trained bidirectional encoder representation, named
329
+ DNABERT, to capture global and transferrable understanding of
330
+ genomic DNA sequences based on up and downstream nucleotide
331
+ contexts. We compared DNABERT to the most widely used programs
332
+ for genome-wide regulatory elements prediction and demonstrate
333
+ its ease of use, accuracy and efficiency. We show that the
334
+ single pre-trained transformers model can simultaneously achieve
335
+ state-of-the-art performance on prediction of promoters, splice
336
+ sites and transcription factor binding sites, after easy
337
+ fine-tuning using small task-specific labeled data. Further,
338
+ DNABERT enables direct visualization of nucleotide-level
339
+ importance and semantic relationship within input sequences for
340
+ better interpretability and accurate identification of conserved
341
+ sequence motifs and functional genetic variant candidates.
342
+ Finally, we demonstrate that pre-trained DNABERT with human
343
+ genome can even be readily applied to other organisms with
344
+ exceptional performance. We anticipate that the pre-trained
345
+ DNABERT model can be fined tuned to many other sequence analyses
346
+ tasks. AVAILABILITY AND IMPLEMENTATION: The source code,
347
+ pretrained and finetuned model for DNABERT are available at
348
+ GitHub (https://github.com/jerryji1993/DNABERT). SUPPLEMENTARY
349
+ INFORMATION: Supplementary data are available at Bioinformatics
350
+ online.",
351
+ journal = "Bioinformatics",
352
+ publisher = "Oxford University Press (OUP)",
353
+ volume = 37,
354
+ number = 15,
355
+ pages = "2112--2120",
356
+ month = aug,
357
+ year = 2021,
358
+ copyright = "https://academic.oup.com/journals/pages/open\_access/funder\_policies/chorus/standard\_publication\_model",
359
+ language = "en"
360
+ }
361
+ ```
362
+
363
+ > [!NOTE]
364
+ > The artifacts distributed in this repository are part of the MultiMolecule project.
365
+ > If you use MultiMolecule in your research, you must cite the MultiMolecule project as follows:
366
+
367
+ ```bibtex
368
+ @software{chen_2024_12638419,
369
+ author = {Chen, Zhiyuan and Zhu, Sophia Y.},
370
+ title = {MultiMolecule},
371
+ doi = {10.5281/zenodo.12638419},
372
+ publisher = {Zenodo},
373
+ url = {https://doi.org/10.5281/zenodo.12638419},
374
+ year = 2024,
375
+ month = may,
376
+ day = 4
377
+ }
378
+ ```
379
+
380
+ ## Contact
381
+
382
+ Please use GitHub issues of [MultiMolecule](https://github.com/DLS5-Omics/multimolecule/issues) for any questions or comments on the model card.
383
+
384
+ Please contact the authors of the [DNABERT paper](https://doi.org/10.1093/bioinformatics/btab083) for questions or comments on the paper/model.
385
+
386
+ ## License
387
+
388
+ This model is licensed under the [GNU Affero General Public License](license.md).
389
+
390
+ For additional terms and clarifications, please refer to our [License FAQ](license-faq.md).
391
+
392
+ ```spdx
393
+ SPDX-License-Identifier: AGPL-3.0-or-later
394
+ ```
config.json ADDED
@@ -0,0 +1,39 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ {
2
+ "add_cross_attention": false,
3
+ "architectures": [
4
+ "DnaBertForMaskedLM"
5
+ ],
6
+ "attention_dropout": 0.1,
7
+ "bos_token_id": 0,
8
+ "dtype": "float32",
9
+ "eos_token_id": 2,
10
+ "head": null,
11
+ "hidden_act": "gelu",
12
+ "hidden_dropout": 0.1,
13
+ "hidden_size": 768,
14
+ "id2label": {
15
+ "0": "LABEL_0"
16
+ },
17
+ "initializer_range": 0.02,
18
+ "intermediate_size": 3072,
19
+ "is_decoder": false,
20
+ "label2id": {
21
+ "LABEL_0": 0
22
+ },
23
+ "layer_norm_eps": 1e-12,
24
+ "lm_head": null,
25
+ "mask_token_id": 4,
26
+ "max_position_embeddings": 512,
27
+ "model_type": "dnabert",
28
+ "null_token_id": 5,
29
+ "num_attention_heads": 12,
30
+ "num_hidden_layers": 12,
31
+ "pad_token_id": 0,
32
+ "position_embedding_type": "absolute",
33
+ "tie_word_embeddings": true,
34
+ "transformers_version": "5.2.0",
35
+ "type_vocab_size": 2,
36
+ "unk_token_id": 3,
37
+ "use_cache": true,
38
+ "vocab_size": 1030
39
+ }
license-faq.md ADDED
@@ -0,0 +1,299 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ # License FAQ
2
+
3
+ This License FAQ (Frequently Asked Questions) clarifies the terms and conditions governing the use of the materials in the MultiMolecule project (the "MultiMolecule") provided by the DanLing Team (also known as DanLing) ("we," "us," or "our").
4
+ This FAQ serves as an addendum to, and is incorporated by reference into, the [GNU Affero General Public License (AGPL)](license.md) (the "License").
5
+ This FAQ and the License together constitute the entire agreement (the "Agreement") between you and us regarding your use of MultiMolecule.
6
+ Capitalized terms used but not defined in this FAQ have the meanings given to them in the AGPL.
7
+
8
+ ## 0. Summary of Key Points
9
+
10
+ This summary highlights the key aspects of our license.
11
+ For more detailed information, please refer to the corresponding sections below and read the [License](license.md).
12
+
13
+ <div class="grid cards" markdown>
14
+
15
+ !!! question "What are source code and object code in MultiMolecule?"
16
+
17
+ The Source Code includes all materials necessary to develop, train, evaluate, and run a model, including data, code, configuration, and documentation.
18
+ The Object Code includes model weight files and compiled code.
19
+
20
+ [:octicons-arrow-right-24: What are source code and object code in MultiMolecule?](#1-what-are-source-code-and-object-code-in-multimolecule)
21
+
22
+ !!! question "Am I required to share my trained model?"
23
+
24
+ If you Convey model weight files hosted and distributed by MultiMolecule, you must convey those weight files under the Agreement, along with the Corresponding Source.
25
+ If you Convey modified versions of such weight files (for example, fine-tuned weights), you must convey those modified weight files under the Agreement, along with the Corresponding Source.
26
+ These obligations apply regardless of whether you used MultiMolecule, a third-party library, or a customized training pipeline to produce the conveyed weights.
27
+
28
+ [:octicons-arrow-right-24: Am I required to share my trained model?](#2-am-i-required-to-share-my-trained-model)
29
+
30
+ !!! question "Am I required to share the data used for training?"
31
+
32
+ If you Convey any model weights covered by Section 2, you must also provide to recipients under the Agreement any training datasets used to train, update, or modify those weights, excluding data used solely for evaluation as clarified in Section 3.
33
+
34
+ [:octicons-arrow-right-24: Am I required to share the data used for training?](#3-am-i-required-to-share-the-data-used-for-training)
35
+
36
+ !!! question "Do I need to acknowledge MultiMolecule?"
37
+
38
+ We strongly encourage acknowledgement whenever MultiMolecule contributes to your work.
39
+ Citation is strongly requested for all research papers and becomes mandatory only as a condition of additional permissions granted in Section 5 or Section 8.
40
+ Reasonable author attribution in Appropriate Legal Notices is required in certain distributed interactive interfaces.
41
+
42
+ [:octicons-arrow-right-24: Do I need to acknowledge MultiMolecule?](#4-do-i-need-to-acknowledge-multimolecule)
43
+
44
+ !!! question "Can I publish research papers using MultiMolecule?"
45
+
46
+ If your manuscript or supplements include MultiMolecule materials (as described in Section 5), then the manuscript and supplements must be distributed under the License unless an additional permission applies.
47
+ Section 5 and Section 8 grant additional permissions to enable publication in certain venues under manuscript-sharing licenses, subject to Section 6.
48
+ If you cannot comply with the License and do not qualify for an additional permission, you may not distribute the manuscript or supplements with MultiMolecule materials.
49
+
50
+ [:octicons-arrow-right-24: Can I publish research papers using MultiMolecule?](#5-can-i-publish-research-papers-using-multimolecule)
51
+
52
+ !!! question "Is there any restriction on publishing research papers in certain venues?"
53
+
54
+ Yes, there are restrictions on publishing research papers in certain venues under the additional permissions granted by this FAQ.
55
+ Section 6 limits only additional permissions granted by this FAQ.
56
+ Section 6 does not restrict publication under the [License](license.md) itself.
57
+
58
+ [:octicons-arrow-right-24: Restrictions on Publishing Research Papers in Certain Venues](#6-restrictions-on-publishing-research-papers-in-certain-venues)
59
+
60
+ !!! question "Can I use MultiMolecule for commercial purposes?"
61
+
62
+ Yes, you can use MultiMolecule for commercial purposes under the terms of the Agreement.
63
+ If you prefer commercial use without the obligations that apply when you Convey covered materials, you must obtain a separate license.
64
+
65
+ [:octicons-arrow-right-24: Can I use MultiMolecule for commercial purposes?](#7-can-i-use-multimolecule-for-commercial-purposes)
66
+
67
+ !!! question "Are there special permissions for MultiMolecule Collaborators?"
68
+
69
+ Yes, recognized Collaborators are granted specific additional permissions pursuant to Section 7 of the License.
70
+ These permissions are subject to the stated conditions and to Section 6.
71
+
72
+ [:octicons-arrow-right-24: Are there special permissions for MultiMolecule Collaborators?](#8-are-there-special-permissions-for-multimolecule-collaborators)
73
+
74
+ </div>
75
+
76
+ ## 1. What are source code and object code in MultiMolecule?
77
+
78
+ For all materials in the MultiMolecule project, the following definitions clarify and supplement those found in the [License](license.md).
79
+
80
+ > [!TIP] Scope of materials hosted by MultiMolecule
81
+ > Unless explicitly stated otherwise in the relevant model card, dataset card, file header, directory notice, or accompanying LICENSE/NOTICE, all model weights, datasets, code, configuration, and documentation hosted and distributed by MultiMolecule are provided under the Agreement.
82
+ > If we host any specific item under different terms in the future, we will explicitly label that item, and the stated terms will control for that item.
83
+
84
+ > [!IMPORTANT] Source Code
85
+ > **Source Code** refers to the preferred form of the licensed materials for making modifications thereto, consistent with Section 1 of the License.
86
+ > It encompasses all materials necessary for developing, training, evaluating and running the models.
87
+
88
+ Source Code includes, but is not limited to:
89
+
90
+ - **Data**: The datasets, in the form needed for processing, that are required for training, evaluating, or running the models provided or generated as part of the licensed materials.
91
+ - **Code**: All source code for scripts, programs, libraries (including model architecture and pipeline definitions), and utilities required to process data, train models, perform evaluations, deploy the models, or otherwise operate and modify the licensed materials.
92
+ - **Configuration**: Configuration files, settings parameters, environmental specifications, and any scripts used to control the installation, compilation, training, evaluation, running, or execution processes related to the licensed materials.
93
+ - **Documentation**: Interface definition files, build instructions, manuals, guides, research papers and technical reports distributed by MultiMolecule as part of the licensed materials describing the specific methodologies, architectures and parameters used, and any other technical documentation necessary to understand, install, operate, and modify the licensed materials.
94
+
95
+ *Providing the Source Code as defined here is necessary to satisfy the requirement to provide the "Corresponding Source" under the Agreement (and where applicable, under the License) when conveying Object Code.*
96
+
97
+ > [!IMPORTANT] Object Code
98
+ > **Object Code** refers to any form of the licensed materials that is not Source Code.
99
+
100
+ Object Code primarily includes, but is not limited to:
101
+
102
+ - **Model Weights**: The numerical parameters representing the learned state of a model after training (e.g., files in SafeTensors, HDF5, or similar formats).
103
+ This includes all model weights provided or hosted by MultiMolecule except for those stated otherwise.
104
+ This also includes any fine-tuned model weights derived from model weights provided or hosted by MultiMolecule.
105
+ - **Compiled Code**: Any executable software code not in human-readable source form, like compiled C++ extensions sometimes found in Python packages.
106
+
107
+ *For model weights treated as Object Code in MultiMolecule, the Corresponding Source includes, at a minimum, the training data and the scripts needed to reproduce the conveyed weights.*
108
+
109
+ Understanding this distinction helps clarify your obligations under the Agreement.
110
+ For instance, if you Convey Object Code (like model weights), you must also ensure the corresponding Source Code (including the necessary data, code, configuration, and documentation) is available under the terms of the Agreement.
111
+
112
+ ## 2. Am I required to share my trained model?
113
+
114
+ If you Convey model weights covered by the Agreement, you must convey those weights under the Agreement, along with the Corresponding Source.
115
+
116
+ As explained in Section 1 of this FAQ, model weights are treated as Object Code in MultiMolecule.
117
+ Whenever you Convey Object Code under the Agreement, you must also provide the Corresponding Source.
118
+ For model weights covered by the Agreement, Corresponding Source includes, at a minimum, the code, training data, configuration, and scripts needed to reproduce, install, run, and modify the conveyed weights, as clarified in Section 1 of this FAQ.
119
+
120
+ If you modify MultiMolecule and you provide users remote interaction with your modified version through a computer network, you must comply with Section 13 of the License by offering the Corresponding Source of your modified version to those users.
121
+ This Section 13 obligation concerns remote interaction with the modified MultiMolecule Program itself.
122
+
123
+ Section 3 specifies the training-data requirement.
124
+
125
+ ## 3. Am I required to share the data used for training?
126
+
127
+ If you Convey model weights covered by the Agreement, you must also provide to recipients under the Agreement any training datasets used to train, update, or modify those weights, excluding data used solely for evaluation as clarified below.
128
+
129
+ As explained in Section 1 of this FAQ, training datasets are treated as Source Code in MultiMolecule.
130
+ Accordingly, whenever you are required to provide Corresponding Source under the Agreement, the required Corresponding Source includes the training data required to reproduce the conveyed weights, as clarified in Section 1 of this FAQ.
131
+
132
+ This requirement applies only to data used to train, update, or modify the conveyed model weights.
133
+ Data used solely for evaluation is not required under this provision, provided it was not also used for training.
134
+
135
+ If the required training data cannot be provided to recipients under the Agreement, you may not Convey the resulting weights under the Agreement.
136
+
137
+ ## 4. Do I need to acknowledge MultiMolecule?
138
+
139
+ We strongly encourage acknowledgement whenever MultiMolecule contributes to your work.
140
+ This section distinguishes
141
+
142
+ - (a) what we strongly request as a community norm, and
143
+ - (b) what becomes mandatory as a condition of additional permissions granted by this FAQ.
144
+
145
+ > [!NOTE]
146
+ > We strongly encourage formal citation in any research paper that uses MultiMolecule.
147
+ > If you publish a paper solely under the [License](license.md), citation is not a condition of license compliance, but it is strongly requested.
148
+ > If you rely on an additional permission in Section 5 or Section 8, formal citation is a condition of that additional permission.
149
+
150
+ When citation is required under this FAQ (e.g., as a condition of an additional permission in Section 5 or Section 8), it must include, at a minimum, the project name (“MultiMolecule”) and the DOI ([10.5281/zenodo.12638419](https://doi.org/10.5281/zenodo.12638419)).
151
+ If the venue does not support formal citations, the project name and DOI must instead appear in the acknowledgments section.
152
+
153
+ > [!IMPORTANT]
154
+ > If you Convey a program that incorporates MultiMolecule, you must preserve a reasonable author attribution for MultiMolecule in the Appropriate Legal Notices.
155
+
156
+ If the Program has an interactive user interface, it must display Appropriate Legal Notices.
157
+ Those notices must include a reasonable author attribution for MultiMolecule, including the project name and a link to the official repository or website.
158
+
159
+ For command-line programs, this attribution must be shown prominently at startup and be available via `--help`, `--version`, or `--about` where applicable.
160
+ For web services, this attribution must be shown prominently on the main page or another readily accessible location.
161
+
162
+ For libraries or non-interactive components, this attribution must be shown prominently in the documentation and, if the component provides any interactive interface, in that interface.
163
+
164
+ ## 5. Can I publish research papers using MultiMolecule?
165
+
166
+ > [!IMPORTANT]
167
+ > As clarified in Section 1, Documentation is part of Source Code in MultiMolecule.
168
+ > Accordingly, if your manuscript or supplements include MultiMolecule materials (i.e., contain or reproduce MultiMolecule code, weights, datasets, documentation text, figures, or other MultiMolecule materials), then the manuscript and supplements are treated as Documentation distributed with those MultiMolecule materials.
169
+ > This requirement concerns manuscripts and supplements that include MultiMolecule materials, not separate and independent works that are merely distributed alongside MultiMolecule.
170
+ > Therefore, absent an additional permission, the manuscript and supplements that include MultiMolecule materials must be distributed under the License to the extent the manuscript or supplements contain or reproduce MultiMolecule materials, as part of the same distribution of those MultiMolecule materials.
171
+ > If you cannot comply with the License, you may not distribute the manuscript or supplements with MultiMolecule materials under the Agreement.
172
+
173
+ This section grants additional permissions under Section 7 of the License for specific publication scenarios in which authors prefer to release manuscripts under manuscript-sharing licenses.
174
+ For avoidance of doubt, the additional permissions in this Section 5 apply only to the manuscript text and other documentary materials.
175
+ They do not alter the License that governs any MultiMolecule code, model weights, or datasets that you Convey, which remain under the Agreement unless explicitly stated otherwise.
176
+
177
+
178
+ > [!IMPORTANT]
179
+ > If you rely on any additional permission in this Section 5, formal citation as described in Section 4 is a condition of that additional permission.
180
+ > Any additional permission granted in this Section 5 remains subject to Section 6.
181
+
182
+ > [!TIP] Diamond Open Access
183
+ > Diamond open access venues are permitted under the additional permissions below.
184
+
185
+ You may publish manuscripts that Convey MultiMolecule materials in fully open access journals, conferences, or platforms that do not charge fees to either authors or readers.
186
+
187
+ The public version of the manuscript must be made available under a license that permits sharing of manuscripts.
188
+ You may use one of the following licenses.
189
+
190
+ - GNU Free Documentation License (GFDL)
191
+ - Creative Commons licenses
192
+ - OSI-approved licenses
193
+
194
+ This permission is granted as an additional permission under Section 7 of the [License](license.md).
195
+
196
+ > [!WARNING] Non-Profit
197
+ > Certain non-profit venues are permitted under the additional permissions below.
198
+
199
+ You may publish manuscripts that Convey MultiMolecule materials in certain non-profit journals, conferences, or platforms.
200
+
201
+ This includes the following venues.
202
+
203
+ - eLife
204
+
205
+ This permission is granted as an additional permission under Section 7 of the [License](license.md).
206
+
207
+ > [!CAUTION] Closed-Access / Author-Fee
208
+ > Closed-access or author-fee venues often make compliance impossible.
209
+
210
+ We do not endorse publishing MultiMolecule materials in closed-access or author-fee venues.
211
+
212
+ If a venue’s terms would prevent you from complying with the License for any MultiMolecule materials you Convey in connection with the publication, you must obtain a separate written license agreement from us prior to submission or publication.
213
+ Such an agreement may involve conditions such as co-authorship or financial contributions to the project.
214
+
215
+ ## 6. Restrictions on Publishing Research Papers in Certain Venues
216
+
217
+ > [!IMPORTANT]
218
+ > This section limits only additional permissions granted by this FAQ.
219
+ > This section does not restrict publication under the [License](license.md) itself.
220
+ > If you Convey MultiMolecule materials as part of a publication and you comply with the License for those materials, Section 6 does not apply.
221
+
222
+ Accordingly, Section 6 constrains only the additional permissions in Section 5 and Section 8.
223
+ Section 6 also constrains any separate written license agreement that incorporates or references this FAQ, unless that separate agreement expressly states otherwise in writing.
224
+
225
+ We believe that free and open access to research is a cornerstone of the machine learning community.
226
+ Inspired by the [Statement on Nature Machine Intelligence](https://openaccess.engineering.oregonstate.edu), and by the ongoing culture of [zero-cost open access](https://diamasproject.eu), we hold that research should be universally accessible without barriers to authors or readers.
227
+
228
+ The following publication venues adopt closed-access or author-fee models that contradict these fundamental values.
229
+ We view such practices as a regressive step in the evolution of machine learning research dissemination, one that undermines community efforts to foster open collaboration and knowledge sharing.
230
+
231
+ - Nature Machine Intelligence
232
+
233
+ Notwithstanding Sections 5 and 8, none of the additional permissions granted by this FAQ authorize submission or publication of a manuscript that Conveys MultiMolecule materials in the venues listed above.
234
+ You may submit or publish such a manuscript in the venues listed above only if you have a separate written license agreement from us that expressly permits publication notwithstanding this Section 6.
235
+
236
+ We strongly discourage publishing work that Conveys MultiMolecule materials in the venues listed above.
237
+
238
+ ## 7. Can I use MultiMolecule for commercial purposes?
239
+
240
+ Yes.
241
+ You may use MultiMolecule for commercial purposes, provided you comply with the Agreement.
242
+
243
+ If you Convey modified MultiMolecule materials, you must provide the Corresponding Source and related artifacts required by the License and this FAQ.
244
+
245
+ Where applicable, this includes training data as clarified in Section 3 and model weights as clarified in Section 2.
246
+
247
+ If you prefer commercial use without making such materials available under the License, you must obtain a separate written license agreement from us.
248
+ Please contact [license@danling.org](mailto:license@danling.org) for details.
249
+
250
+ ## 8. Are there special permissions for MultiMolecule Collaborators?
251
+
252
+ Yes.
253
+ If you are recognized as a Collaborator by the DanLing Team, you are entitled to the following additional permissions granted under Section 7 of the [License](license.md).
254
+
255
+ > [!TIP] Internal network use waiver
256
+ > Notwithstanding Section 13 of the License, Collaborators receive a waiver of the obligation to offer Corresponding Source to users interacting remotely through a computer network with a modified version of MultiMolecule, provided that the interaction is solely for internal research and development within the Collaborator’s team.
257
+ > This waiver does not apply to external users, public deployments, or Conveyance.
258
+
259
+ > [!TIP] Expanded permission for publishing papers
260
+ > Collaborators may publish manuscripts that Convey MultiMolecule materials in any peer-reviewed scientific venue, including journals and conference proceedings, regardless of access model or author fees.
261
+ > This expanded permission is granted as an additional permission under Section 7 of the [License](license.md).
262
+ > This expanded permission remains subject to Section 6 of this FAQ.
263
+ > This expanded permission affects only the licensing of the manuscript and supplementary documentation, and does not alter the License that governs any MultiMolecule materials you Convey.
264
+ > As a condition of this expanded permission, you must comply with the acknowledgement and citation requirements in Section 4.
265
+
266
+ > [!IMPORTANT] Source release timing related to publications
267
+ > This additional permission concerns the timing of *public release* of publication-related modifications.
268
+ > It does not delay any obligation under the License to provide Corresponding Source to recipients upon Conveyance, or to remote users upon network interaction under Section 13.
269
+ > If your modifications are utilized in research described in a manuscript, you must make the Corresponding Source for those publication-related modifications publicly available upon the first of the following events.
270
+ >
271
+ > - The manuscript’s formal acceptance for publication in a peer-reviewed venue.
272
+ > - 366 days have passed since the manuscript was first posted on a public preprint server.
273
+ >
274
+ > You must make the public release immediately upon the first applicable trigger event.
275
+ > If modifications are Conveyed or made available for remote interaction through a computer network in ways not tied to a publication or preprint, the standard timing rules of the License apply.
276
+
277
+ > [!NOTE] General conditions for Collaborator permissions
278
+ > These permissions are granted only to active, invited Collaborators recognized by the DanLing Team.
279
+ > These permissions are non-transferable and non-sublicensable.
280
+ > All other provisions of the License and this FAQ remain in full force and effect unless explicitly modified above.
281
+ > The DanLing Team may grant additional case-specific permissions through written communication.
282
+
283
+ ## 9. How can I use MultiMolecule if my organization forbids the use of code under the AGPL License?
284
+
285
+ Certain organizations, such as [Google](https://opensource.google/documentation/reference/using/agpl-policy), prohibit the use of AGPL-licensed code.
286
+ If you are affiliated with an organization that disallows the use of AGPL-licensed software, you must obtain a separate license from us to use MultiMolecule.
287
+
288
+ To request a separate license, please contact us at [license@danling.org](mailto:license@danling.org).
289
+
290
+ ## 10. Do we make updates to this FAQ?
291
+
292
+ > [!TIP] "In Short"
293
+ > Yes, we will update this FAQ as necessary to stay compliant with relevant laws.
294
+
295
+ We may update this license FAQ from time to time.
296
+ The updated version will be indicated by an updated 'Last Revised Time' at the bottom of this license FAQ.
297
+ If we make any material changes, we will notify you by posting the new license FAQ on this page.
298
+ We are unable to notify you directly as we do not collect any contact information from you.
299
+ We encourage you to review this license FAQ frequently to stay informed of how you can use our data, models, code, configuration, and documentation.
license.md ADDED
@@ -0,0 +1,661 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ # GNU AFFERO GENERAL PUBLIC LICENSE
2
+
3
+ Version 3, 19 November 2007
4
+
5
+ Copyright (C) 2007 Free Software Foundation, Inc.
6
+ <https://fsf.org/>
7
+
8
+ Everyone is permitted to copy and distribute verbatim copies of this
9
+ license document, but changing it is not allowed.
10
+
11
+ ## Preamble
12
+
13
+ The GNU Affero General Public License is a free, copyleft license for
14
+ software and other kinds of works, specifically designed to ensure
15
+ cooperation with the community in the case of network server software.
16
+
17
+ The licenses for most software and other practical works are designed
18
+ to take away your freedom to share and change the works. By contrast,
19
+ our General Public Licenses are intended to guarantee your freedom to
20
+ share and change all versions of a program--to make sure it remains
21
+ free software for all its users.
22
+
23
+ When we speak of free software, we are referring to freedom, not
24
+ price. Our General Public Licenses are designed to make sure that you
25
+ have the freedom to distribute copies of free software (and charge for
26
+ them if you wish), that you receive source code or can get it if you
27
+ want it, that you can change the software or use pieces of it in new
28
+ free programs, and that you know you can do these things.
29
+
30
+ Developers that use our General Public Licenses protect your rights
31
+ with two steps: (1) assert copyright on the software, and (2) offer
32
+ you this License which gives you legal permission to copy, distribute
33
+ and/or modify the software.
34
+
35
+ A secondary benefit of defending all users' freedom is that
36
+ improvements made in alternate versions of the program, if they
37
+ receive widespread use, become available for other developers to
38
+ incorporate. Many developers of free software are heartened and
39
+ encouraged by the resulting cooperation. However, in the case of
40
+ software used on network servers, this result may fail to come about.
41
+ The GNU General Public License permits making a modified version and
42
+ letting the public access it on a server without ever releasing its
43
+ source code to the public.
44
+
45
+ The GNU Affero General Public License is designed specifically to
46
+ ensure that, in such cases, the modified source code becomes available
47
+ to the community. It requires the operator of a network server to
48
+ provide the source code of the modified version running there to the
49
+ users of that server. Therefore, public use of a modified version, on
50
+ a publicly accessible server, gives the public access to the source
51
+ code of the modified version.
52
+
53
+ An older license, called the Affero General Public License and
54
+ published by Affero, was designed to accomplish similar goals. This is
55
+ a different license, not a version of the Affero GPL, but Affero has
56
+ released a new version of the Affero GPL which permits relicensing
57
+ under this license.
58
+
59
+ The precise terms and conditions for copying, distribution and
60
+ modification follow.
61
+
62
+ ## TERMS AND CONDITIONS
63
+
64
+ ### 0. Definitions.
65
+
66
+ "This License" refers to version 3 of the GNU Affero General Public
67
+ License.
68
+
69
+ "Copyright" also means copyright-like laws that apply to other kinds
70
+ of works, such as semiconductor masks.
71
+
72
+ "The Program" refers to any copyrightable work licensed under this
73
+ License. Each licensee is addressed as "you". "Licensees" and
74
+ "recipients" may be individuals or organizations.
75
+
76
+ To "modify" a work means to copy from or adapt all or part of the work
77
+ in a fashion requiring copyright permission, other than the making of
78
+ an exact copy. The resulting work is called a "modified version" of
79
+ the earlier work or a work "based on" the earlier work.
80
+
81
+ A "covered work" means either the unmodified Program or a work based
82
+ on the Program.
83
+
84
+ To "propagate" a work means to do anything with it that, without
85
+ permission, would make you directly or secondarily liable for
86
+ infringement under applicable copyright law, except executing it on a
87
+ computer or modifying a private copy. Propagation includes copying,
88
+ distribution (with or without modification), making available to the
89
+ public, and in some countries other activities as well.
90
+
91
+ To "convey" a work means any kind of propagation that enables other
92
+ parties to make or receive copies. Mere interaction with a user
93
+ through a computer network, with no transfer of a copy, is not
94
+ conveying.
95
+
96
+ An interactive user interface displays "Appropriate Legal Notices" to
97
+ the extent that it includes a convenient and prominently visible
98
+ feature that (1) displays an appropriate copyright notice, and (2)
99
+ tells the user that there is no warranty for the work (except to the
100
+ extent that warranties are provided), that licensees may convey the
101
+ work under this License, and how to view a copy of this License. If
102
+ the interface presents a list of user commands or options, such as a
103
+ menu, a prominent item in the list meets this criterion.
104
+
105
+ ### 1. Source Code.
106
+
107
+ The "source code" for a work means the preferred form of the work for
108
+ making modifications to it. "Object code" means any non-source form of
109
+ a work.
110
+
111
+ A "Standard Interface" means an interface that either is an official
112
+ standard defined by a recognized standards body, or, in the case of
113
+ interfaces specified for a particular programming language, one that
114
+ is widely used among developers working in that language.
115
+
116
+ The "System Libraries" of an executable work include anything, other
117
+ than the work as a whole, that (a) is included in the normal form of
118
+ packaging a Major Component, but which is not part of that Major
119
+ Component, and (b) serves only to enable use of the work with that
120
+ Major Component, or to implement a Standard Interface for which an
121
+ implementation is available to the public in source code form. A
122
+ "Major Component", in this context, means a major essential component
123
+ (kernel, window system, and so on) of the specific operating system
124
+ (if any) on which the executable work runs, or a compiler used to
125
+ produce the work, or an object code interpreter used to run it.
126
+
127
+ The "Corresponding Source" for a work in object code form means all
128
+ the source code needed to generate, install, and (for an executable
129
+ work) run the object code and to modify the work, including scripts to
130
+ control those activities. However, it does not include the work's
131
+ System Libraries, or general-purpose tools or generally available free
132
+ programs which are used unmodified in performing those activities but
133
+ which are not part of the work. For example, Corresponding Source
134
+ includes interface definition files associated with source files for
135
+ the work, and the source code for shared libraries and dynamically
136
+ linked subprograms that the work is specifically designed to require,
137
+ such as by intimate data communication or control flow between those
138
+ subprograms and other parts of the work.
139
+
140
+ The Corresponding Source need not include anything that users can
141
+ regenerate automatically from other parts of the Corresponding Source.
142
+
143
+ The Corresponding Source for a work in source code form is that same
144
+ work.
145
+
146
+ ### 2. Basic Permissions.
147
+
148
+ All rights granted under this License are granted for the term of
149
+ copyright on the Program, and are irrevocable provided the stated
150
+ conditions are met. This License explicitly affirms your unlimited
151
+ permission to run the unmodified Program. The output from running a
152
+ covered work is covered by this License only if the output, given its
153
+ content, constitutes a covered work. This License acknowledges your
154
+ rights of fair use or other equivalent, as provided by copyright law.
155
+
156
+ You may make, run and propagate covered works that you do not convey,
157
+ without conditions so long as your license otherwise remains in force.
158
+ You may convey covered works to others for the sole purpose of having
159
+ them make modifications exclusively for you, or provide you with
160
+ facilities for running those works, provided that you comply with the
161
+ terms of this License in conveying all material for which you do not
162
+ control copyright. Those thus making or running the covered works for
163
+ you must do so exclusively on your behalf, under your direction and
164
+ control, on terms that prohibit them from making any copies of your
165
+ copyrighted material outside their relationship with you.
166
+
167
+ Conveying under any other circumstances is permitted solely under the
168
+ conditions stated below. Sublicensing is not allowed; section 10 makes
169
+ it unnecessary.
170
+
171
+ ### 3. Protecting Users' Legal Rights From Anti-Circumvention Law.
172
+
173
+ No covered work shall be deemed part of an effective technological
174
+ measure under any applicable law fulfilling obligations under article
175
+ 11 of the WIPO copyright treaty adopted on 20 December 1996, or
176
+ similar laws prohibiting or restricting circumvention of such
177
+ measures.
178
+
179
+ When you convey a covered work, you waive any legal power to forbid
180
+ circumvention of technological measures to the extent such
181
+ circumvention is effected by exercising rights under this License with
182
+ respect to the covered work, and you disclaim any intention to limit
183
+ operation or modification of the work as a means of enforcing, against
184
+ the work's users, your or third parties' legal rights to forbid
185
+ circumvention of technological measures.
186
+
187
+ ### 4. Conveying Verbatim Copies.
188
+
189
+ You may convey verbatim copies of the Program's source code as you
190
+ receive it, in any medium, provided that you conspicuously and
191
+ appropriately publish on each copy an appropriate copyright notice;
192
+ keep intact all notices stating that this License and any
193
+ non-permissive terms added in accord with section 7 apply to the code;
194
+ keep intact all notices of the absence of any warranty; and give all
195
+ recipients a copy of this License along with the Program.
196
+
197
+ You may charge any price or no price for each copy that you convey,
198
+ and you may offer support or warranty protection for a fee.
199
+
200
+ ### 5. Conveying Modified Source Versions.
201
+
202
+ You may convey a work based on the Program, or the modifications to
203
+ produce it from the Program, in the form of source code under the
204
+ terms of section 4, provided that you also meet all of these
205
+ conditions:
206
+
207
+ - a) The work must carry prominent notices stating that you modified
208
+ it, and giving a relevant date.
209
+ - b) The work must carry prominent notices stating that it is
210
+ released under this License and any conditions added under
211
+ section 7. This requirement modifies the requirement in section 4
212
+ to "keep intact all notices".
213
+ - c) You must license the entire work, as a whole, under this
214
+ License to anyone who comes into possession of a copy. This
215
+ License will therefore apply, along with any applicable section 7
216
+ additional terms, to the whole of the work, and all its parts,
217
+ regardless of how they are packaged. This License gives no
218
+ permission to license the work in any other way, but it does not
219
+ invalidate such permission if you have separately received it.
220
+ - d) If the work has interactive user interfaces, each must display
221
+ Appropriate Legal Notices; however, if the Program has interactive
222
+ interfaces that do not display Appropriate Legal Notices, your
223
+ work need not make them do so.
224
+
225
+ A compilation of a covered work with other separate and independent
226
+ works, which are not by their nature extensions of the covered work,
227
+ and which are not combined with it such as to form a larger program,
228
+ in or on a volume of a storage or distribution medium, is called an
229
+ "aggregate" if the compilation and its resulting copyright are not
230
+ used to limit the access or legal rights of the compilation's users
231
+ beyond what the individual works permit. Inclusion of a covered work
232
+ in an aggregate does not cause this License to apply to the other
233
+ parts of the aggregate.
234
+
235
+ ### 6. Conveying Non-Source Forms.
236
+
237
+ You may convey a covered work in object code form under the terms of
238
+ sections 4 and 5, provided that you also convey the machine-readable
239
+ Corresponding Source under the terms of this License, in one of these
240
+ ways:
241
+
242
+ - a) Convey the object code in, or embodied in, a physical product
243
+ (including a physical distribution medium), accompanied by the
244
+ Corresponding Source fixed on a durable physical medium
245
+ customarily used for software interchange.
246
+ - b) Convey the object code in, or embodied in, a physical product
247
+ (including a physical distribution medium), accompanied by a
248
+ written offer, valid for at least three years and valid for as
249
+ long as you offer spare parts or customer support for that product
250
+ model, to give anyone who possesses the object code either (1) a
251
+ copy of the Corresponding Source for all the software in the
252
+ product that is covered by this License, on a durable physical
253
+ medium customarily used for software interchange, for a price no
254
+ more than your reasonable cost of physically performing this
255
+ conveying of source, or (2) access to copy the Corresponding
256
+ Source from a network server at no charge.
257
+ - c) Convey individual copies of the object code with a copy of the
258
+ written offer to provide the Corresponding Source. This
259
+ alternative is allowed only occasionally and noncommercially, and
260
+ only if you received the object code with such an offer, in accord
261
+ with subsection 6b.
262
+ - d) Convey the object code by offering access from a designated
263
+ place (gratis or for a charge), and offer equivalent access to the
264
+ Corresponding Source in the same way through the same place at no
265
+ further charge. You need not require recipients to copy the
266
+ Corresponding Source along with the object code. If the place to
267
+ copy the object code is a network server, the Corresponding Source
268
+ may be on a different server (operated by you or a third party)
269
+ that supports equivalent copying facilities, provided you maintain
270
+ clear directions next to the object code saying where to find the
271
+ Corresponding Source. Regardless of what server hosts the
272
+ Corresponding Source, you remain obligated to ensure that it is
273
+ available for as long as needed to satisfy these requirements.
274
+ - e) Convey the object code using peer-to-peer transmission,
275
+ provided you inform other peers where the object code and
276
+ Corresponding Source of the work are being offered to the general
277
+ public at no charge under subsection 6d.
278
+
279
+ A separable portion of the object code, whose source code is excluded
280
+ from the Corresponding Source as a System Library, need not be
281
+ included in conveying the object code work.
282
+
283
+ A "User Product" is either (1) a "consumer product", which means any
284
+ tangible personal property which is normally used for personal,
285
+ family, or household purposes, or (2) anything designed or sold for
286
+ incorporation into a dwelling. In determining whether a product is a
287
+ consumer product, doubtful cases shall be resolved in favor of
288
+ coverage. For a particular product received by a particular user,
289
+ "normally used" refers to a typical or common use of that class of
290
+ product, regardless of the status of the particular user or of the way
291
+ in which the particular user actually uses, or expects or is expected
292
+ to use, the product. A product is a consumer product regardless of
293
+ whether the product has substantial commercial, industrial or
294
+ non-consumer uses, unless such uses represent the only significant
295
+ mode of use of the product.
296
+
297
+ "Installation Information" for a User Product means any methods,
298
+ procedures, authorization keys, or other information required to
299
+ install and execute modified versions of a covered work in that User
300
+ Product from a modified version of its Corresponding Source. The
301
+ information must suffice to ensure that the continued functioning of
302
+ the modified object code is in no case prevented or interfered with
303
+ solely because modification has been made.
304
+
305
+ If you convey an object code work under this section in, or with, or
306
+ specifically for use in, a User Product, and the conveying occurs as
307
+ part of a transaction in which the right of possession and use of the
308
+ User Product is transferred to the recipient in perpetuity or for a
309
+ fixed term (regardless of how the transaction is characterized), the
310
+ Corresponding Source conveyed under this section must be accompanied
311
+ by the Installation Information. But this requirement does not apply
312
+ if neither you nor any third party retains the ability to install
313
+ modified object code on the User Product (for example, the work has
314
+ been installed in ROM).
315
+
316
+ The requirement to provide Installation Information does not include a
317
+ requirement to continue to provide support service, warranty, or
318
+ updates for a work that has been modified or installed by the
319
+ recipient, or for the User Product in which it has been modified or
320
+ installed. Access to a network may be denied when the modification
321
+ itself materially and adversely affects the operation of the network
322
+ or violates the rules and protocols for communication across the
323
+ network.
324
+
325
+ Corresponding Source conveyed, and Installation Information provided,
326
+ in accord with this section must be in a format that is publicly
327
+ documented (and with an implementation available to the public in
328
+ source code form), and must require no special password or key for
329
+ unpacking, reading or copying.
330
+
331
+ ### 7. Additional Terms.
332
+
333
+ "Additional permissions" are terms that supplement the terms of this
334
+ License by making exceptions from one or more of its conditions.
335
+ Additional permissions that are applicable to the entire Program shall
336
+ be treated as though they were included in this License, to the extent
337
+ that they are valid under applicable law. If additional permissions
338
+ apply only to part of the Program, that part may be used separately
339
+ under those permissions, but the entire Program remains governed by
340
+ this License without regard to the additional permissions.
341
+
342
+ When you convey a copy of a covered work, you may at your option
343
+ remove any additional permissions from that copy, or from any part of
344
+ it. (Additional permissions may be written to require their own
345
+ removal in certain cases when you modify the work.) You may place
346
+ additional permissions on material, added by you to a covered work,
347
+ for which you have or can give appropriate copyright permission.
348
+
349
+ Notwithstanding any other provision of this License, for material you
350
+ add to a covered work, you may (if authorized by the copyright holders
351
+ of that material) supplement the terms of this License with terms:
352
+
353
+ - a) Disclaiming warranty or limiting liability differently from the
354
+ terms of sections 15 and 16 of this License; or
355
+ - b) Requiring preservation of specified reasonable legal notices or
356
+ author attributions in that material or in the Appropriate Legal
357
+ Notices displayed by works containing it; or
358
+ - c) Prohibiting misrepresentation of the origin of that material,
359
+ or requiring that modified versions of such material be marked in
360
+ reasonable ways as different from the original version; or
361
+ - d) Limiting the use for publicity purposes of names of licensors
362
+ or authors of the material; or
363
+ - e) Declining to grant rights under trademark law for use of some
364
+ trade names, trademarks, or service marks; or
365
+ - f) Requiring indemnification of licensors and authors of that
366
+ material by anyone who conveys the material (or modified versions
367
+ of it) with contractual assumptions of liability to the recipient,
368
+ for any liability that these contractual assumptions directly
369
+ impose on those licensors and authors.
370
+
371
+ All other non-permissive additional terms are considered "further
372
+ restrictions" within the meaning of section 10. If the Program as you
373
+ received it, or any part of it, contains a notice stating that it is
374
+ governed by this License along with a term that is a further
375
+ restriction, you may remove that term. If a license document contains
376
+ a further restriction but permits relicensing or conveying under this
377
+ License, you may add to a covered work material governed by the terms
378
+ of that license document, provided that the further restriction does
379
+ not survive such relicensing or conveying.
380
+
381
+ If you add terms to a covered work in accord with this section, you
382
+ must place, in the relevant source files, a statement of the
383
+ additional terms that apply to those files, or a notice indicating
384
+ where to find the applicable terms.
385
+
386
+ Additional terms, permissive or non-permissive, may be stated in the
387
+ form of a separately written license, or stated as exceptions; the
388
+ above requirements apply either way.
389
+
390
+ ### 8. Termination.
391
+
392
+ You may not propagate or modify a covered work except as expressly
393
+ provided under this License. Any attempt otherwise to propagate or
394
+ modify it is void, and will automatically terminate your rights under
395
+ this License (including any patent licenses granted under the third
396
+ paragraph of section 11).
397
+
398
+ However, if you cease all violation of this License, then your license
399
+ from a particular copyright holder is reinstated (a) provisionally,
400
+ unless and until the copyright holder explicitly and finally
401
+ terminates your license, and (b) permanently, if the copyright holder
402
+ fails to notify you of the violation by some reasonable means prior to
403
+ 60 days after the cessation.
404
+
405
+ Moreover, your license from a particular copyright holder is
406
+ reinstated permanently if the copyright holder notifies you of the
407
+ violation by some reasonable means, this is the first time you have
408
+ received notice of violation of this License (for any work) from that
409
+ copyright holder, and you cure the violation prior to 30 days after
410
+ your receipt of the notice.
411
+
412
+ Termination of your rights under this section does not terminate the
413
+ licenses of parties who have received copies or rights from you under
414
+ this License. If your rights have been terminated and not permanently
415
+ reinstated, you do not qualify to receive new licenses for the same
416
+ material under section 10.
417
+
418
+ ### 9. Acceptance Not Required for Having Copies.
419
+
420
+ You are not required to accept this License in order to receive or run
421
+ a copy of the Program. Ancillary propagation of a covered work
422
+ occurring solely as a consequence of using peer-to-peer transmission
423
+ to receive a copy likewise does not require acceptance. However,
424
+ nothing other than this License grants you permission to propagate or
425
+ modify any covered work. These actions infringe copyright if you do
426
+ not accept this License. Therefore, by modifying or propagating a
427
+ covered work, you indicate your acceptance of this License to do so.
428
+
429
+ ### 10. Automatic Licensing of Downstream Recipients.
430
+
431
+ Each time you convey a covered work, the recipient automatically
432
+ receives a license from the original licensors, to run, modify and
433
+ propagate that work, subject to this License. You are not responsible
434
+ for enforcing compliance by third parties with this License.
435
+
436
+ An "entity transaction" is a transaction transferring control of an
437
+ organization, or substantially all assets of one, or subdividing an
438
+ organization, or merging organizations. If propagation of a covered
439
+ work results from an entity transaction, each party to that
440
+ transaction who receives a copy of the work also receives whatever
441
+ licenses to the work the party's predecessor in interest had or could
442
+ give under the previous paragraph, plus a right to possession of the
443
+ Corresponding Source of the work from the predecessor in interest, if
444
+ the predecessor has it or can get it with reasonable efforts.
445
+
446
+ You may not impose any further restrictions on the exercise of the
447
+ rights granted or affirmed under this License. For example, you may
448
+ not impose a license fee, royalty, or other charge for exercise of
449
+ rights granted under this License, and you may not initiate litigation
450
+ (including a cross-claim or counterclaim in a lawsuit) alleging that
451
+ any patent claim is infringed by making, using, selling, offering for
452
+ sale, or importing the Program or any portion of it.
453
+
454
+ ### 11. Patents.
455
+
456
+ A "contributor" is a copyright holder who authorizes use under this
457
+ License of the Program or a work on which the Program is based. The
458
+ work thus licensed is called the contributor's "contributor version".
459
+
460
+ A contributor's "essential patent claims" are all patent claims owned
461
+ or controlled by the contributor, whether already acquired or
462
+ hereafter acquired, that would be infringed by some manner, permitted
463
+ by this License, of making, using, or selling its contributor version,
464
+ but do not include claims that would be infringed only as a
465
+ consequence of further modification of the contributor version. For
466
+ purposes of this definition, "control" includes the right to grant
467
+ patent sublicenses in a manner consistent with the requirements of
468
+ this License.
469
+
470
+ Each contributor grants you a non-exclusive, worldwide, royalty-free
471
+ patent license under the contributor's essential patent claims, to
472
+ make, use, sell, offer for sale, import and otherwise run, modify and
473
+ propagate the contents of its contributor version.
474
+
475
+ In the following three paragraphs, a "patent license" is any express
476
+ agreement or commitment, however denominated, not to enforce a patent
477
+ (such as an express permission to practice a patent or covenant not to
478
+ sue for patent infringement). To "grant" such a patent license to a
479
+ party means to make such an agreement or commitment not to enforce a
480
+ patent against the party.
481
+
482
+ If you convey a covered work, knowingly relying on a patent license,
483
+ and the Corresponding Source of the work is not available for anyone
484
+ to copy, free of charge and under the terms of this License, through a
485
+ publicly available network server or other readily accessible means,
486
+ then you must either (1) cause the Corresponding Source to be so
487
+ available, or (2) arrange to deprive yourself of the benefit of the
488
+ patent license for this particular work, or (3) arrange, in a manner
489
+ consistent with the requirements of this License, to extend the patent
490
+ license to downstream recipients. "Knowingly relying" means you have
491
+ actual knowledge that, but for the patent license, your conveying the
492
+ covered work in a country, or your recipient's use of the covered work
493
+ in a country, would infringe one or more identifiable patents in that
494
+ country that you have reason to believe are valid.
495
+
496
+ If, pursuant to or in connection with a single transaction or
497
+ arrangement, you convey, or propagate by procuring conveyance of, a
498
+ covered work, and grant a patent license to some of the parties
499
+ receiving the covered work authorizing them to use, propagate, modify
500
+ or convey a specific copy of the covered work, then the patent license
501
+ you grant is automatically extended to all recipients of the covered
502
+ work and works based on it.
503
+
504
+ A patent license is "discriminatory" if it does not include within the
505
+ scope of its coverage, prohibits the exercise of, or is conditioned on
506
+ the non-exercise of one or more of the rights that are specifically
507
+ granted under this License. You may not convey a covered work if you
508
+ are a party to an arrangement with a third party that is in the
509
+ business of distributing software, under which you make payment to the
510
+ third party based on the extent of your activity of conveying the
511
+ work, and under which the third party grants, to any of the parties
512
+ who would receive the covered work from you, a discriminatory patent
513
+ license (a) in connection with copies of the covered work conveyed by
514
+ you (or copies made from those copies), or (b) primarily for and in
515
+ connection with specific products or compilations that contain the
516
+ covered work, unless you entered into that arrangement, or that patent
517
+ license was granted, prior to 28 March 2007.
518
+
519
+ Nothing in this License shall be construed as excluding or limiting
520
+ any implied license or other defenses to infringement that may
521
+ otherwise be available to you under applicable patent law.
522
+
523
+ ### 12. No Surrender of Others' Freedom.
524
+
525
+ If conditions are imposed on you (whether by court order, agreement or
526
+ otherwise) that contradict the conditions of this License, they do not
527
+ excuse you from the conditions of this License. If you cannot convey a
528
+ covered work so as to satisfy simultaneously your obligations under
529
+ this License and any other pertinent obligations, then as a
530
+ consequence you may not convey it at all. For example, if you agree to
531
+ terms that obligate you to collect a royalty for further conveying
532
+ from those to whom you convey the Program, the only way you could
533
+ satisfy both those terms and this License would be to refrain entirely
534
+ from conveying the Program.
535
+
536
+ ### 13. Remote Network Interaction; Use with the GNU General Public License.
537
+
538
+ Notwithstanding any other provision of this License, if you modify the
539
+ Program, your modified version must prominently offer all users
540
+ interacting with it remotely through a computer network (if your
541
+ version supports such interaction) an opportunity to receive the
542
+ Corresponding Source of your version by providing access to the
543
+ Corresponding Source from a network server at no charge, through some
544
+ standard or customary means of facilitating copying of software. This
545
+ Corresponding Source shall include the Corresponding Source for any
546
+ work covered by version 3 of the GNU General Public License that is
547
+ incorporated pursuant to the following paragraph.
548
+
549
+ Notwithstanding any other provision of this License, you have
550
+ permission to link or combine any covered work with a work licensed
551
+ under version 3 of the GNU General Public License into a single
552
+ combined work, and to convey the resulting work. The terms of this
553
+ License will continue to apply to the part which is the covered work,
554
+ but the work with which it is combined will remain governed by version
555
+ 3 of the GNU General Public License.
556
+
557
+ ### 14. Revised Versions of this License.
558
+
559
+ The Free Software Foundation may publish revised and/or new versions
560
+ of the GNU Affero General Public License from time to time. Such new
561
+ versions will be similar in spirit to the present version, but may
562
+ differ in detail to address new problems or concerns.
563
+
564
+ Each version is given a distinguishing version number. If the Program
565
+ specifies that a certain numbered version of the GNU Affero General
566
+ Public License "or any later version" applies to it, you have the
567
+ option of following the terms and conditions either of that numbered
568
+ version or of any later version published by the Free Software
569
+ Foundation. If the Program does not specify a version number of the
570
+ GNU Affero General Public License, you may choose any version ever
571
+ published by the Free Software Foundation.
572
+
573
+ If the Program specifies that a proxy can decide which future versions
574
+ of the GNU Affero General Public License can be used, that proxy's
575
+ public statement of acceptance of a version permanently authorizes you
576
+ to choose that version for the Program.
577
+
578
+ Later license versions may give you additional or different
579
+ permissions. However, no additional obligations are imposed on any
580
+ author or copyright holder as a result of your choosing to follow a
581
+ later version.
582
+
583
+ ### 15. Disclaimer of Warranty.
584
+
585
+ THERE IS NO WARRANTY FOR THE PROGRAM, TO THE EXTENT PERMITTED BY
586
+ APPLICABLE LAW. EXCEPT WHEN OTHERWISE STATED IN WRITING THE COPYRIGHT
587
+ HOLDERS AND/OR OTHER PARTIES PROVIDE THE PROGRAM "AS IS" WITHOUT
588
+ WARRANTY OF ANY KIND, EITHER EXPRESSED OR IMPLIED, INCLUDING, BUT NOT
589
+ LIMITED TO, THE IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR
590
+ A PARTICULAR PURPOSE. THE ENTIRE RISK AS TO THE QUALITY AND
591
+ PERFORMANCE OF THE PROGRAM IS WITH YOU. SHOULD THE PROGRAM PROVE
592
+ DEFECTIVE, YOU ASSUME THE COST OF ALL NECESSARY SERVICING, REPAIR OR
593
+ CORRECTION.
594
+
595
+ ### 16. Limitation of Liability.
596
+
597
+ IN NO EVENT UNLESS REQUIRED BY APPLICABLE LAW OR AGREED TO IN WRITING
598
+ WILL ANY COPYRIGHT HOLDER, OR ANY OTHER PARTY WHO MODIFIES AND/OR
599
+ CONVEYS THE PROGRAM AS PERMITTED ABOVE, BE LIABLE TO YOU FOR DAMAGES,
600
+ INCLUDING ANY GENERAL, SPECIAL, INCIDENTAL OR CONSEQUENTIAL DAMAGES
601
+ ARISING OUT OF THE USE OR INABILITY TO USE THE PROGRAM (INCLUDING BUT
602
+ NOT LIMITED TO LOSS OF DATA OR DATA BEING RENDERED INACCURATE OR
603
+ LOSSES SUSTAINED BY YOU OR THIRD PARTIES OR A FAILURE OF THE PROGRAM
604
+ TO OPERATE WITH ANY OTHER PROGRAMS), EVEN IF SUCH HOLDER OR OTHER
605
+ PARTY HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
606
+
607
+ ### 17. Interpretation of Sections 15 and 16.
608
+
609
+ If the disclaimer of warranty and limitation of liability provided
610
+ above cannot be given local legal effect according to their terms,
611
+ reviewing courts shall apply local law that most closely approximates
612
+ an absolute waiver of all civil liability in connection with the
613
+ Program, unless a warranty or assumption of liability accompanies a
614
+ copy of the Program in return for a fee.
615
+
616
+ END OF TERMS AND CONDITIONS
617
+
618
+ ## How to Apply These Terms to Your New Programs
619
+
620
+ If you develop a new program, and you want it to be of the greatest
621
+ possible use to the public, the best way to achieve this is to make it
622
+ free software which everyone can redistribute and change under these
623
+ terms.
624
+
625
+ To do so, attach the following notices to the program. It is safest to
626
+ attach them to the start of each source file to most effectively state
627
+ the exclusion of warranty; and each file should have at least the
628
+ "copyright" line and a pointer to where the full notice is found.
629
+
630
+ <one line to give the program's name and a brief idea of what it does.>
631
+ Copyright (C) <year> <name of author>
632
+
633
+ This program is free software: you can redistribute it and/or modify
634
+ it under the terms of the GNU Affero General Public License as
635
+ published by the Free Software Foundation, either version 3 of the
636
+ License, or (at your option) any later version.
637
+
638
+ This program is distributed in the hope that it will be useful,
639
+ but WITHOUT ANY WARRANTY; without even the implied warranty of
640
+ MERCHANTABILITY or FITNESS FOR A PARTICULAR PURPOSE. See the
641
+ GNU Affero General Public License for more details.
642
+
643
+ You should have received a copy of the GNU Affero General Public License
644
+ along with this program. If not, see <https://www.gnu.org/licenses/>.
645
+
646
+ Also add information on how to contact you by electronic and paper
647
+ mail.
648
+
649
+ If your software can interact with users remotely through a computer
650
+ network, you should also make sure that it provides a way for users to
651
+ get its source. For example, if your program is a web application, its
652
+ interface could display a "Source" link that leads users to an archive
653
+ of the code. There are many ways you could offer source, and different
654
+ solutions will be better for different programs; see section 13 for
655
+ the specific requirements.
656
+
657
+ You should also get your employer (if you work as a programmer) or
658
+ school, if any, to sign a "copyright disclaimer" for the program, if
659
+ necessary. For more information on this, and how to apply and follow
660
+ the GNU AGPL, see <https://www.gnu.org/licenses/>.
661
+
model.safetensors ADDED
@@ -0,0 +1,3 @@
 
 
 
 
1
+ version https://git-lfs.github.com/spec/v1
2
+ oid sha256:6e831bb1375d0c81501527199c884af4f4db1a79956d9913a9661b7e736307eb
3
+ size 350527856
tokenizer_config.json ADDED
@@ -0,0 +1,69 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ {
2
+ "added_tokens_decoder": {
3
+ "0": {
4
+ "content": "<pad>",
5
+ "lstrip": false,
6
+ "normalized": false,
7
+ "rstrip": false,
8
+ "single_word": false,
9
+ "special": true
10
+ },
11
+ "1": {
12
+ "content": "<cls>",
13
+ "lstrip": false,
14
+ "normalized": false,
15
+ "rstrip": false,
16
+ "single_word": false,
17
+ "special": true
18
+ },
19
+ "2": {
20
+ "content": "<eos>",
21
+ "lstrip": false,
22
+ "normalized": false,
23
+ "rstrip": false,
24
+ "single_word": false,
25
+ "special": true
26
+ },
27
+ "3": {
28
+ "content": "<unk>",
29
+ "lstrip": false,
30
+ "normalized": false,
31
+ "rstrip": false,
32
+ "single_word": false,
33
+ "special": true
34
+ },
35
+ "4": {
36
+ "content": "<mask>",
37
+ "lstrip": false,
38
+ "normalized": false,
39
+ "rstrip": false,
40
+ "single_word": false,
41
+ "special": true
42
+ },
43
+ "5": {
44
+ "content": "<null>",
45
+ "lstrip": false,
46
+ "normalized": false,
47
+ "rstrip": false,
48
+ "single_word": false,
49
+ "special": true
50
+ }
51
+ },
52
+ "backend": "custom",
53
+ "bos_token": "<cls>",
54
+ "clean_up_tokenization_spaces": true,
55
+ "cls_token": "<cls>",
56
+ "codon": false,
57
+ "eos_token": "<eos>",
58
+ "extra_special_tokens": [
59
+ "<null>"
60
+ ],
61
+ "mask_token": "<mask>",
62
+ "model_max_length": 512,
63
+ "nmers": 5,
64
+ "pad_token": "<pad>",
65
+ "replace_U_with_T": true,
66
+ "sep_token": "<eos>",
67
+ "tokenizer_class": "DnaTokenizer",
68
+ "unk_token": "<unk>"
69
+ }
vocab.txt ADDED
@@ -0,0 +1,1030 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ <pad>
2
+ <cls>
3
+ <eos>
4
+ <unk>
5
+ <mask>
6
+ <null>
7
+ AAAAA
8
+ AAAAC
9
+ AAAAG
10
+ AAAAT
11
+ AAACA
12
+ AAACC
13
+ AAACG
14
+ AAACT
15
+ AAAGA
16
+ AAAGC
17
+ AAAGG
18
+ AAAGT
19
+ AAATA
20
+ AAATC
21
+ AAATG
22
+ AAATT
23
+ AACAA
24
+ AACAC
25
+ AACAG
26
+ AACAT
27
+ AACCA
28
+ AACCC
29
+ AACCG
30
+ AACCT
31
+ AACGA
32
+ AACGC
33
+ AACGG
34
+ AACGT
35
+ AACTA
36
+ AACTC
37
+ AACTG
38
+ AACTT
39
+ AAGAA
40
+ AAGAC
41
+ AAGAG
42
+ AAGAT
43
+ AAGCA
44
+ AAGCC
45
+ AAGCG
46
+ AAGCT
47
+ AAGGA
48
+ AAGGC
49
+ AAGGG
50
+ AAGGT
51
+ AAGTA
52
+ AAGTC
53
+ AAGTG
54
+ AAGTT
55
+ AATAA
56
+ AATAC
57
+ AATAG
58
+ AATAT
59
+ AATCA
60
+ AATCC
61
+ AATCG
62
+ AATCT
63
+ AATGA
64
+ AATGC
65
+ AATGG
66
+ AATGT
67
+ AATTA
68
+ AATTC
69
+ AATTG
70
+ AATTT
71
+ ACAAA
72
+ ACAAC
73
+ ACAAG
74
+ ACAAT
75
+ ACACA
76
+ ACACC
77
+ ACACG
78
+ ACACT
79
+ ACAGA
80
+ ACAGC
81
+ ACAGG
82
+ ACAGT
83
+ ACATA
84
+ ACATC
85
+ ACATG
86
+ ACATT
87
+ ACCAA
88
+ ACCAC
89
+ ACCAG
90
+ ACCAT
91
+ ACCCA
92
+ ACCCC
93
+ ACCCG
94
+ ACCCT
95
+ ACCGA
96
+ ACCGC
97
+ ACCGG
98
+ ACCGT
99
+ ACCTA
100
+ ACCTC
101
+ ACCTG
102
+ ACCTT
103
+ ACGAA
104
+ ACGAC
105
+ ACGAG
106
+ ACGAT
107
+ ACGCA
108
+ ACGCC
109
+ ACGCG
110
+ ACGCT
111
+ ACGGA
112
+ ACGGC
113
+ ACGGG
114
+ ACGGT
115
+ ACGTA
116
+ ACGTC
117
+ ACGTG
118
+ ACGTT
119
+ ACTAA
120
+ ACTAC
121
+ ACTAG
122
+ ACTAT
123
+ ACTCA
124
+ ACTCC
125
+ ACTCG
126
+ ACTCT
127
+ ACTGA
128
+ ACTGC
129
+ ACTGG
130
+ ACTGT
131
+ ACTTA
132
+ ACTTC
133
+ ACTTG
134
+ ACTTT
135
+ AGAAA
136
+ AGAAC
137
+ AGAAG
138
+ AGAAT
139
+ AGACA
140
+ AGACC
141
+ AGACG
142
+ AGACT
143
+ AGAGA
144
+ AGAGC
145
+ AGAGG
146
+ AGAGT
147
+ AGATA
148
+ AGATC
149
+ AGATG
150
+ AGATT
151
+ AGCAA
152
+ AGCAC
153
+ AGCAG
154
+ AGCAT
155
+ AGCCA
156
+ AGCCC
157
+ AGCCG
158
+ AGCCT
159
+ AGCGA
160
+ AGCGC
161
+ AGCGG
162
+ AGCGT
163
+ AGCTA
164
+ AGCTC
165
+ AGCTG
166
+ AGCTT
167
+ AGGAA
168
+ AGGAC
169
+ AGGAG
170
+ AGGAT
171
+ AGGCA
172
+ AGGCC
173
+ AGGCG
174
+ AGGCT
175
+ AGGGA
176
+ AGGGC
177
+ AGGGG
178
+ AGGGT
179
+ AGGTA
180
+ AGGTC
181
+ AGGTG
182
+ AGGTT
183
+ AGTAA
184
+ AGTAC
185
+ AGTAG
186
+ AGTAT
187
+ AGTCA
188
+ AGTCC
189
+ AGTCG
190
+ AGTCT
191
+ AGTGA
192
+ AGTGC
193
+ AGTGG
194
+ AGTGT
195
+ AGTTA
196
+ AGTTC
197
+ AGTTG
198
+ AGTTT
199
+ ATAAA
200
+ ATAAC
201
+ ATAAG
202
+ ATAAT
203
+ ATACA
204
+ ATACC
205
+ ATACG
206
+ ATACT
207
+ ATAGA
208
+ ATAGC
209
+ ATAGG
210
+ ATAGT
211
+ ATATA
212
+ ATATC
213
+ ATATG
214
+ ATATT
215
+ ATCAA
216
+ ATCAC
217
+ ATCAG
218
+ ATCAT
219
+ ATCCA
220
+ ATCCC
221
+ ATCCG
222
+ ATCCT
223
+ ATCGA
224
+ ATCGC
225
+ ATCGG
226
+ ATCGT
227
+ ATCTA
228
+ ATCTC
229
+ ATCTG
230
+ ATCTT
231
+ ATGAA
232
+ ATGAC
233
+ ATGAG
234
+ ATGAT
235
+ ATGCA
236
+ ATGCC
237
+ ATGCG
238
+ ATGCT
239
+ ATGGA
240
+ ATGGC
241
+ ATGGG
242
+ ATGGT
243
+ ATGTA
244
+ ATGTC
245
+ ATGTG
246
+ ATGTT
247
+ ATTAA
248
+ ATTAC
249
+ ATTAG
250
+ ATTAT
251
+ ATTCA
252
+ ATTCC
253
+ ATTCG
254
+ ATTCT
255
+ ATTGA
256
+ ATTGC
257
+ ATTGG
258
+ ATTGT
259
+ ATTTA
260
+ ATTTC
261
+ ATTTG
262
+ ATTTT
263
+ CAAAA
264
+ CAAAC
265
+ CAAAG
266
+ CAAAT
267
+ CAACA
268
+ CAACC
269
+ CAACG
270
+ CAACT
271
+ CAAGA
272
+ CAAGC
273
+ CAAGG
274
+ CAAGT
275
+ CAATA
276
+ CAATC
277
+ CAATG
278
+ CAATT
279
+ CACAA
280
+ CACAC
281
+ CACAG
282
+ CACAT
283
+ CACCA
284
+ CACCC
285
+ CACCG
286
+ CACCT
287
+ CACGA
288
+ CACGC
289
+ CACGG
290
+ CACGT
291
+ CACTA
292
+ CACTC
293
+ CACTG
294
+ CACTT
295
+ CAGAA
296
+ CAGAC
297
+ CAGAG
298
+ CAGAT
299
+ CAGCA
300
+ CAGCC
301
+ CAGCG
302
+ CAGCT
303
+ CAGGA
304
+ CAGGC
305
+ CAGGG
306
+ CAGGT
307
+ CAGTA
308
+ CAGTC
309
+ CAGTG
310
+ CAGTT
311
+ CATAA
312
+ CATAC
313
+ CATAG
314
+ CATAT
315
+ CATCA
316
+ CATCC
317
+ CATCG
318
+ CATCT
319
+ CATGA
320
+ CATGC
321
+ CATGG
322
+ CATGT
323
+ CATTA
324
+ CATTC
325
+ CATTG
326
+ CATTT
327
+ CCAAA
328
+ CCAAC
329
+ CCAAG
330
+ CCAAT
331
+ CCACA
332
+ CCACC
333
+ CCACG
334
+ CCACT
335
+ CCAGA
336
+ CCAGC
337
+ CCAGG
338
+ CCAGT
339
+ CCATA
340
+ CCATC
341
+ CCATG
342
+ CCATT
343
+ CCCAA
344
+ CCCAC
345
+ CCCAG
346
+ CCCAT
347
+ CCCCA
348
+ CCCCC
349
+ CCCCG
350
+ CCCCT
351
+ CCCGA
352
+ CCCGC
353
+ CCCGG
354
+ CCCGT
355
+ CCCTA
356
+ CCCTC
357
+ CCCTG
358
+ CCCTT
359
+ CCGAA
360
+ CCGAC
361
+ CCGAG
362
+ CCGAT
363
+ CCGCA
364
+ CCGCC
365
+ CCGCG
366
+ CCGCT
367
+ CCGGA
368
+ CCGGC
369
+ CCGGG
370
+ CCGGT
371
+ CCGTA
372
+ CCGTC
373
+ CCGTG
374
+ CCGTT
375
+ CCTAA
376
+ CCTAC
377
+ CCTAG
378
+ CCTAT
379
+ CCTCA
380
+ CCTCC
381
+ CCTCG
382
+ CCTCT
383
+ CCTGA
384
+ CCTGC
385
+ CCTGG
386
+ CCTGT
387
+ CCTTA
388
+ CCTTC
389
+ CCTTG
390
+ CCTTT
391
+ CGAAA
392
+ CGAAC
393
+ CGAAG
394
+ CGAAT
395
+ CGACA
396
+ CGACC
397
+ CGACG
398
+ CGACT
399
+ CGAGA
400
+ CGAGC
401
+ CGAGG
402
+ CGAGT
403
+ CGATA
404
+ CGATC
405
+ CGATG
406
+ CGATT
407
+ CGCAA
408
+ CGCAC
409
+ CGCAG
410
+ CGCAT
411
+ CGCCA
412
+ CGCCC
413
+ CGCCG
414
+ CGCCT
415
+ CGCGA
416
+ CGCGC
417
+ CGCGG
418
+ CGCGT
419
+ CGCTA
420
+ CGCTC
421
+ CGCTG
422
+ CGCTT
423
+ CGGAA
424
+ CGGAC
425
+ CGGAG
426
+ CGGAT
427
+ CGGCA
428
+ CGGCC
429
+ CGGCG
430
+ CGGCT
431
+ CGGGA
432
+ CGGGC
433
+ CGGGG
434
+ CGGGT
435
+ CGGTA
436
+ CGGTC
437
+ CGGTG
438
+ CGGTT
439
+ CGTAA
440
+ CGTAC
441
+ CGTAG
442
+ CGTAT
443
+ CGTCA
444
+ CGTCC
445
+ CGTCG
446
+ CGTCT
447
+ CGTGA
448
+ CGTGC
449
+ CGTGG
450
+ CGTGT
451
+ CGTTA
452
+ CGTTC
453
+ CGTTG
454
+ CGTTT
455
+ CTAAA
456
+ CTAAC
457
+ CTAAG
458
+ CTAAT
459
+ CTACA
460
+ CTACC
461
+ CTACG
462
+ CTACT
463
+ CTAGA
464
+ CTAGC
465
+ CTAGG
466
+ CTAGT
467
+ CTATA
468
+ CTATC
469
+ CTATG
470
+ CTATT
471
+ CTCAA
472
+ CTCAC
473
+ CTCAG
474
+ CTCAT
475
+ CTCCA
476
+ CTCCC
477
+ CTCCG
478
+ CTCCT
479
+ CTCGA
480
+ CTCGC
481
+ CTCGG
482
+ CTCGT
483
+ CTCTA
484
+ CTCTC
485
+ CTCTG
486
+ CTCTT
487
+ CTGAA
488
+ CTGAC
489
+ CTGAG
490
+ CTGAT
491
+ CTGCA
492
+ CTGCC
493
+ CTGCG
494
+ CTGCT
495
+ CTGGA
496
+ CTGGC
497
+ CTGGG
498
+ CTGGT
499
+ CTGTA
500
+ CTGTC
501
+ CTGTG
502
+ CTGTT
503
+ CTTAA
504
+ CTTAC
505
+ CTTAG
506
+ CTTAT
507
+ CTTCA
508
+ CTTCC
509
+ CTTCG
510
+ CTTCT
511
+ CTTGA
512
+ CTTGC
513
+ CTTGG
514
+ CTTGT
515
+ CTTTA
516
+ CTTTC
517
+ CTTTG
518
+ CTTTT
519
+ GAAAA
520
+ GAAAC
521
+ GAAAG
522
+ GAAAT
523
+ GAACA
524
+ GAACC
525
+ GAACG
526
+ GAACT
527
+ GAAGA
528
+ GAAGC
529
+ GAAGG
530
+ GAAGT
531
+ GAATA
532
+ GAATC
533
+ GAATG
534
+ GAATT
535
+ GACAA
536
+ GACAC
537
+ GACAG
538
+ GACAT
539
+ GACCA
540
+ GACCC
541
+ GACCG
542
+ GACCT
543
+ GACGA
544
+ GACGC
545
+ GACGG
546
+ GACGT
547
+ GACTA
548
+ GACTC
549
+ GACTG
550
+ GACTT
551
+ GAGAA
552
+ GAGAC
553
+ GAGAG
554
+ GAGAT
555
+ GAGCA
556
+ GAGCC
557
+ GAGCG
558
+ GAGCT
559
+ GAGGA
560
+ GAGGC
561
+ GAGGG
562
+ GAGGT
563
+ GAGTA
564
+ GAGTC
565
+ GAGTG
566
+ GAGTT
567
+ GATAA
568
+ GATAC
569
+ GATAG
570
+ GATAT
571
+ GATCA
572
+ GATCC
573
+ GATCG
574
+ GATCT
575
+ GATGA
576
+ GATGC
577
+ GATGG
578
+ GATGT
579
+ GATTA
580
+ GATTC
581
+ GATTG
582
+ GATTT
583
+ GCAAA
584
+ GCAAC
585
+ GCAAG
586
+ GCAAT
587
+ GCACA
588
+ GCACC
589
+ GCACG
590
+ GCACT
591
+ GCAGA
592
+ GCAGC
593
+ GCAGG
594
+ GCAGT
595
+ GCATA
596
+ GCATC
597
+ GCATG
598
+ GCATT
599
+ GCCAA
600
+ GCCAC
601
+ GCCAG
602
+ GCCAT
603
+ GCCCA
604
+ GCCCC
605
+ GCCCG
606
+ GCCCT
607
+ GCCGA
608
+ GCCGC
609
+ GCCGG
610
+ GCCGT
611
+ GCCTA
612
+ GCCTC
613
+ GCCTG
614
+ GCCTT
615
+ GCGAA
616
+ GCGAC
617
+ GCGAG
618
+ GCGAT
619
+ GCGCA
620
+ GCGCC
621
+ GCGCG
622
+ GCGCT
623
+ GCGGA
624
+ GCGGC
625
+ GCGGG
626
+ GCGGT
627
+ GCGTA
628
+ GCGTC
629
+ GCGTG
630
+ GCGTT
631
+ GCTAA
632
+ GCTAC
633
+ GCTAG
634
+ GCTAT
635
+ GCTCA
636
+ GCTCC
637
+ GCTCG
638
+ GCTCT
639
+ GCTGA
640
+ GCTGC
641
+ GCTGG
642
+ GCTGT
643
+ GCTTA
644
+ GCTTC
645
+ GCTTG
646
+ GCTTT
647
+ GGAAA
648
+ GGAAC
649
+ GGAAG
650
+ GGAAT
651
+ GGACA
652
+ GGACC
653
+ GGACG
654
+ GGACT
655
+ GGAGA
656
+ GGAGC
657
+ GGAGG
658
+ GGAGT
659
+ GGATA
660
+ GGATC
661
+ GGATG
662
+ GGATT
663
+ GGCAA
664
+ GGCAC
665
+ GGCAG
666
+ GGCAT
667
+ GGCCA
668
+ GGCCC
669
+ GGCCG
670
+ GGCCT
671
+ GGCGA
672
+ GGCGC
673
+ GGCGG
674
+ GGCGT
675
+ GGCTA
676
+ GGCTC
677
+ GGCTG
678
+ GGCTT
679
+ GGGAA
680
+ GGGAC
681
+ GGGAG
682
+ GGGAT
683
+ GGGCA
684
+ GGGCC
685
+ GGGCG
686
+ GGGCT
687
+ GGGGA
688
+ GGGGC
689
+ GGGGG
690
+ GGGGT
691
+ GGGTA
692
+ GGGTC
693
+ GGGTG
694
+ GGGTT
695
+ GGTAA
696
+ GGTAC
697
+ GGTAG
698
+ GGTAT
699
+ GGTCA
700
+ GGTCC
701
+ GGTCG
702
+ GGTCT
703
+ GGTGA
704
+ GGTGC
705
+ GGTGG
706
+ GGTGT
707
+ GGTTA
708
+ GGTTC
709
+ GGTTG
710
+ GGTTT
711
+ GTAAA
712
+ GTAAC
713
+ GTAAG
714
+ GTAAT
715
+ GTACA
716
+ GTACC
717
+ GTACG
718
+ GTACT
719
+ GTAGA
720
+ GTAGC
721
+ GTAGG
722
+ GTAGT
723
+ GTATA
724
+ GTATC
725
+ GTATG
726
+ GTATT
727
+ GTCAA
728
+ GTCAC
729
+ GTCAG
730
+ GTCAT
731
+ GTCCA
732
+ GTCCC
733
+ GTCCG
734
+ GTCCT
735
+ GTCGA
736
+ GTCGC
737
+ GTCGG
738
+ GTCGT
739
+ GTCTA
740
+ GTCTC
741
+ GTCTG
742
+ GTCTT
743
+ GTGAA
744
+ GTGAC
745
+ GTGAG
746
+ GTGAT
747
+ GTGCA
748
+ GTGCC
749
+ GTGCG
750
+ GTGCT
751
+ GTGGA
752
+ GTGGC
753
+ GTGGG
754
+ GTGGT
755
+ GTGTA
756
+ GTGTC
757
+ GTGTG
758
+ GTGTT
759
+ GTTAA
760
+ GTTAC
761
+ GTTAG
762
+ GTTAT
763
+ GTTCA
764
+ GTTCC
765
+ GTTCG
766
+ GTTCT
767
+ GTTGA
768
+ GTTGC
769
+ GTTGG
770
+ GTTGT
771
+ GTTTA
772
+ GTTTC
773
+ GTTTG
774
+ GTTTT
775
+ TAAAA
776
+ TAAAC
777
+ TAAAG
778
+ TAAAT
779
+ TAACA
780
+ TAACC
781
+ TAACG
782
+ TAACT
783
+ TAAGA
784
+ TAAGC
785
+ TAAGG
786
+ TAAGT
787
+ TAATA
788
+ TAATC
789
+ TAATG
790
+ TAATT
791
+ TACAA
792
+ TACAC
793
+ TACAG
794
+ TACAT
795
+ TACCA
796
+ TACCC
797
+ TACCG
798
+ TACCT
799
+ TACGA
800
+ TACGC
801
+ TACGG
802
+ TACGT
803
+ TACTA
804
+ TACTC
805
+ TACTG
806
+ TACTT
807
+ TAGAA
808
+ TAGAC
809
+ TAGAG
810
+ TAGAT
811
+ TAGCA
812
+ TAGCC
813
+ TAGCG
814
+ TAGCT
815
+ TAGGA
816
+ TAGGC
817
+ TAGGG
818
+ TAGGT
819
+ TAGTA
820
+ TAGTC
821
+ TAGTG
822
+ TAGTT
823
+ TATAA
824
+ TATAC
825
+ TATAG
826
+ TATAT
827
+ TATCA
828
+ TATCC
829
+ TATCG
830
+ TATCT
831
+ TATGA
832
+ TATGC
833
+ TATGG
834
+ TATGT
835
+ TATTA
836
+ TATTC
837
+ TATTG
838
+ TATTT
839
+ TCAAA
840
+ TCAAC
841
+ TCAAG
842
+ TCAAT
843
+ TCACA
844
+ TCACC
845
+ TCACG
846
+ TCACT
847
+ TCAGA
848
+ TCAGC
849
+ TCAGG
850
+ TCAGT
851
+ TCATA
852
+ TCATC
853
+ TCATG
854
+ TCATT
855
+ TCCAA
856
+ TCCAC
857
+ TCCAG
858
+ TCCAT
859
+ TCCCA
860
+ TCCCC
861
+ TCCCG
862
+ TCCCT
863
+ TCCGA
864
+ TCCGC
865
+ TCCGG
866
+ TCCGT
867
+ TCCTA
868
+ TCCTC
869
+ TCCTG
870
+ TCCTT
871
+ TCGAA
872
+ TCGAC
873
+ TCGAG
874
+ TCGAT
875
+ TCGCA
876
+ TCGCC
877
+ TCGCG
878
+ TCGCT
879
+ TCGGA
880
+ TCGGC
881
+ TCGGG
882
+ TCGGT
883
+ TCGTA
884
+ TCGTC
885
+ TCGTG
886
+ TCGTT
887
+ TCTAA
888
+ TCTAC
889
+ TCTAG
890
+ TCTAT
891
+ TCTCA
892
+ TCTCC
893
+ TCTCG
894
+ TCTCT
895
+ TCTGA
896
+ TCTGC
897
+ TCTGG
898
+ TCTGT
899
+ TCTTA
900
+ TCTTC
901
+ TCTTG
902
+ TCTTT
903
+ TGAAA
904
+ TGAAC
905
+ TGAAG
906
+ TGAAT
907
+ TGACA
908
+ TGACC
909
+ TGACG
910
+ TGACT
911
+ TGAGA
912
+ TGAGC
913
+ TGAGG
914
+ TGAGT
915
+ TGATA
916
+ TGATC
917
+ TGATG
918
+ TGATT
919
+ TGCAA
920
+ TGCAC
921
+ TGCAG
922
+ TGCAT
923
+ TGCCA
924
+ TGCCC
925
+ TGCCG
926
+ TGCCT
927
+ TGCGA
928
+ TGCGC
929
+ TGCGG
930
+ TGCGT
931
+ TGCTA
932
+ TGCTC
933
+ TGCTG
934
+ TGCTT
935
+ TGGAA
936
+ TGGAC
937
+ TGGAG
938
+ TGGAT
939
+ TGGCA
940
+ TGGCC
941
+ TGGCG
942
+ TGGCT
943
+ TGGGA
944
+ TGGGC
945
+ TGGGG
946
+ TGGGT
947
+ TGGTA
948
+ TGGTC
949
+ TGGTG
950
+ TGGTT
951
+ TGTAA
952
+ TGTAC
953
+ TGTAG
954
+ TGTAT
955
+ TGTCA
956
+ TGTCC
957
+ TGTCG
958
+ TGTCT
959
+ TGTGA
960
+ TGTGC
961
+ TGTGG
962
+ TGTGT
963
+ TGTTA
964
+ TGTTC
965
+ TGTTG
966
+ TGTTT
967
+ TTAAA
968
+ TTAAC
969
+ TTAAG
970
+ TTAAT
971
+ TTACA
972
+ TTACC
973
+ TTACG
974
+ TTACT
975
+ TTAGA
976
+ TTAGC
977
+ TTAGG
978
+ TTAGT
979
+ TTATA
980
+ TTATC
981
+ TTATG
982
+ TTATT
983
+ TTCAA
984
+ TTCAC
985
+ TTCAG
986
+ TTCAT
987
+ TTCCA
988
+ TTCCC
989
+ TTCCG
990
+ TTCCT
991
+ TTCGA
992
+ TTCGC
993
+ TTCGG
994
+ TTCGT
995
+ TTCTA
996
+ TTCTC
997
+ TTCTG
998
+ TTCTT
999
+ TTGAA
1000
+ TTGAC
1001
+ TTGAG
1002
+ TTGAT
1003
+ TTGCA
1004
+ TTGCC
1005
+ TTGCG
1006
+ TTGCT
1007
+ TTGGA
1008
+ TTGGC
1009
+ TTGGG
1010
+ TTGGT
1011
+ TTGTA
1012
+ TTGTC
1013
+ TTGTG
1014
+ TTGTT
1015
+ TTTAA
1016
+ TTTAC
1017
+ TTTAG
1018
+ TTTAT
1019
+ TTTCA
1020
+ TTTCC
1021
+ TTTCG
1022
+ TTTCT
1023
+ TTTGA
1024
+ TTTGC
1025
+ TTTGG
1026
+ TTTGT
1027
+ TTTTA
1028
+ TTTTC
1029
+ TTTTG
1030
+ TTTTT